Sensitivities and Dependencies of BRAF Mutant Colorectal Cancer Cell Lines with or without PIK3CA Mutations for Discovery of Vulnerabilities with Therapeutic Potential

Background: Colorectal cancer represents a common malignancy and remains incurable in the metastatic stage. Identification of molecular alterations that are present in colorectal cancer has led to the introduction of targeted therapies that improve outcomes. BRAF and PIK3CA mutations are observed in...

Descripción completa

Detalles Bibliográficos
Autor principal: Voutsadakis, Ioannis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608248/
https://www.ncbi.nlm.nih.gov/pubmed/36295658
http://dx.doi.org/10.3390/medicina58101498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608248/
https://www.ncbi.nlm.nih.gov/pubmed/36295658
http://dx.doi.org/10.3390/medicina58101498

Ejemplares similares